59 results
DEFM14A
SQZB
SQZ Biotechnologies Co
23 Jan 24
Proxy related to merger
4:31pm
price.
We cannot predict the timing, amount or nature of any distributions to our stockholders.
See “Risks Related to the Dissolution — We cannot … to stockholder, and the discussions in this proxy statement regarding tax consequences are general in nature.
We have not requested a ruling from
PREM14A
SQZB
SQZ Biotechnologies Co
12 Jan 24
Preliminary proxy related to merger
8:57am
and would likely adversely affect our stock price.
We cannot predict the timing, amount or nature of any distributions to our stockholders.
See “Risks … liquidating distribution may vary from stockholder to stockholder, and the discussions in this proxy statement regarding tax consequences are general in nature
8-K
EX-2.1
SQZB
SQZ Biotechnologies Co
22 Dec 23
Entry into a Material Definitive Agreement
5:18pm
that by their nature are to be satisfied at the Closing, but subject to the satisfaction or waiver of those conditions at such time) are satisfied … to be material to Seller, taken as a whole, in nature or amount) and the absence of notes (that, if presented, would not differ materially from those included
8-K
EX-10.1
0grck6kv5b7gx
7 Jul 23
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.1
fyvngjh52hcu
11 Jul 22
SQZ Biotechnologies Appoints Micah Zajic as Chief Financial Officer
4:49pm
8-K
EX-99.3
ya4tycxghok527ui21j
9 Dec 21
Other Events
7:30am
S-3
EX-4.3
nmkoef iedb8pdon
12 Nov 21
Shelf registration
12:00am
8-K
EX-99.2
izcspfk
13 Sep 21
SQZ Biotechnologies Announces First Autoimmune Disease Indication
6:53am